Financhill
Back

Biomerica 10K Form

Sell
42

BMRA
Biomerica

Last Price:
0.66
Seasonality Move:
2.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BMRA News And Ratings

See the #1 stock for the next 7 days that we like better than BMRA

BMRA Financial Statistics

Sales & Book Value

Annual Sales: $5.34M
Cash Flow: $-1.82M
Price / Cash Flow: 0
Annual Sales: $0.46
Price / Book: 1.43

Profitability

EPS (TTM): -0.37000
Net Income (TTM): $-6.35M
Gross Margin: $446K
Return on Equity: -69.51%
Return on Assets: -54.68%

Biomerica Earnings Forecast

Key Biomerica Financial Ratios

  • The Gross Profit Margin over the past 40 years for BMRA is 8.35%.
  • The Selling, General & Administrative Expenses for BMRA have been equal to 113.97% of Gross Profit Margin.
  • The Research & Development expenses have been 29.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of BMRA is -133.73% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 19 years.

Biomerica Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: BMRA
CUSIP: 09061H
Website: biomerica.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.44
Quick Ratio: 3.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BMRA Technical Analysis vs Fundamental Analysis

Sell
42
Biomerica (BMRA) is a Sell

Is Biomerica a Buy or a Sell?

  • Biomerica stock is rated a Sell
    The current Biomerica [BMRA] share price is $0.67. The Score for BMRA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.